MiRNA profiling of whole trabecular bone: identification of osteoporosis-related changes in MiRNAs in human hip bones
Authors:
- Laura De-UgarteLDLaura De-Ugarte
- Guy YoskovitzGYGuy Yoskovitz
- Susana BalcellsSBSusana Balcells
- Robert Güerri-FernándezRGRobert Güerri-Fernández
- Santos Martinez-DiazSMSantos Martinez-Diaz
- Leonardo MellibovskyLMLeonardo Mellibovsky
- Roser UrreiztiRURoser Urreizti
- Xavier NoguésXNXavier Nogués
- Daniel GrinbergDGDaniel Grinberg
- Natalia García-GiraltNGNatalia García-Giralt
- Adolfo Díez-PérezADAdolfo Díez-Pérez
Open Access
- 10 November 2015
- journal article
- research article
- Published by Springer Nature in BMC Medical Genomics
- Vol. 8 (1) , 1-11
Abstract
MicroRNAs (miRNAs) are important regulators of gene expression, with documented roles in bone metabolism and osteoporosis, suggesting potential therapeutic targets. Our aim was to identify miRNAs differentially expressed in fractured vs nonfractured bones. Additionally, we performed a miRNA profiling of primary osteoblasts to assess the origin of these differentially expressed miRNAs. Total RNA was extracted from (a) fresh femoral neck trabecular bone from women undergoing hip replacement due to either osteoporotic fracture (OP group, n = 6) or osteoarthritis in the absence of osteoporosis (Control group, n = 6), matching the two groups by age and body mass index, and (b) primary osteoblasts obtained from knee replacement due to osteoarthritis (n = 4). Samples were hybridized to a microRNA array containing more than 1900 miRNAs. Principal component analysis (PCA) plots and heat map hierarchical clustering were performed. For comparison of expression levels, the threshold was set at log fold change > 1.5 and a p-value < 0.05 (corrected for multiple testing). Both PCA and heat map analyses showed that the samples clustered according to the presence or absence of fracture. Overall, 790 and 315 different miRNAs were detected in fresh bone samples and in primary osteoblasts, respectively, 293 of which were common to both groups. A subset of 82 miRNAs was differentially expressed (p < 0.05) between osteoporotic and control osteoarthritic samples. The eight miRNAs with the lowest p-values (and for which a validated miRNA qPCR assay was available) were assayed, and two were confirmed: miR-320a and miR-483-5p. Both were over-expressed in the osteoporotic samples and expressed in primary osteoblasts. miR-320a is known to target CTNNB1 and predicted to regulate RUNX2 and LEPR, while miR-483-5p down-regulates IGF2. We observed a reduction trend for this target gene in the osteoporotic bone. We identified two osteoblast miRNAs over-expressed in osteoporotic fractures, which opens novel prospects for research and therapy.Keywords
This publication has 30 references indexed in Scilit:
- WNT signaling in bone homeostasis and disease: from human mutations to treatmentsNature Medicine, 2013
- Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytesBMC Musculoskeletal Disorders, 2012
- DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathwaysNucleic Acids Research, 2012
- MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting β-cateninBiochemical and Biophysical Research Communications, 2012
- MicroRNA control of bone formation and homeostasisNature Reviews Endocrinology, 2012
- MicroRNA biogenesis and regulation of bone remodelingArthritis Research & Therapy, 2011
- Polymorphisms in predicted miRNA binding sites and osteoporosisJournal of Bone and Mineral Research, 2010
- MicroRNA profiling of adrenocortical tumors reveals miR‐483 as a marker of malignancyCancer, 2010
- A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humansJournal of Clinical Investigation, 2009
- MicroRNA-directed transcriptional gene silencing in mammalian cellsProceedings of the National Academy of Sciences, 2008